Company
Krystal Biotech ($KRYS)
Overview
Develops and delivers redosable genetic medicines, including VYJUVEK for dystrophic epidermolysis bullosa, using engineered HSV-1 vectors for serious or rare diseases.
Company
Develops and delivers redosable genetic medicines, including VYJUVEK for dystrophic epidermolysis bullosa, using engineered HSV-1 vectors for serious or rare diseases.